Arkolith/Insider Trading/GLYC/Form 4

Rock Edwin

Chief Medical OfficerGLYCOMIMETICS INC (GLYC) · full profile →Form 4 · filed Jun 24, 2024
Net Buying
Open-Market Buys
$79K
Open-Market Sells
$0
Net Open-Market Flow
$79K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 21, 2024Buy(P)115K$0.27$31K680K
Jun 20, 2024Buy(P)190K$0.25$48K565K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-017978) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for GLYCOMIMETICS INC

Build

Ask your agent about GLYC insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001415889-24-017978"
Ask your agent
Use Arkolith to summarize insider buying and selling at GLYCOMIMETICS INC
over the last 90 days and cite the filings.